Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/IIa Safety, Two-dose Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia

NCT00956332 is registered in ClinicalTrials.gov with MultiGene Vascular Systems Ltd. as lead sponsor.

NCT NCT00956332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00956332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/IIa Safety, Two-dose Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia
Lead sponsor
MultiGene Vascular Systems Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
February 28, 2010
Completion date
May 31, 2026
Enrollment
28 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

critical limb ischemia, peripheral arterial disease, peripheral vascular disease